CORC

在结果中检索

CORC

浏览/检索结果: 共86条，第1-10条 帮助

限定条件                    
已选(0)清除 条数/页：   排序方式：
KATHERINE: Trastuzumab emtansine vs trastuzumab as adjuvant therapy in patients with HER2-positive early breast cancer 会议论文
作者:  Mamounas, Eleftherios P.;  Geyer, Charles E., Jr.;  Huang, Chiun-Sheng;  Mano, Max S.;  Loibl, Sibylle
收藏  |  浏览/下载：21/0  |  提交时间：2019/12/05
Phase III Randomized AUGMENT Study of Lenalidomide/Rituximab vs Rituximab/Placebo in Patients with Relapsed/Refractory Indolent Non-Hodgkin Lymphoma 会议论文
作者:  Gribben, J.;  Trneny, M.;  Izutsu, K.;  Fowler, N. H.;  Hong, X.
收藏  |  浏览/下载：22/0  |  提交时间：2019/12/05
Phase III study of trastuzumab emtansine (T-DM1) vs trastuzumab as adjuvant therapy in patients with HER2-positive early breast cancer with residual invasive disease after neoadjuvant chemotherapy and HER2-targeted therapy including trastuzumab: Primary results from KATHERINE 会议论文
作者:  Geyer, C. E., Jr.;  Huang, C-S;  Mano, M. S.;  Loibl, S.;  Mamounas, E. P.
收藏  |  浏览/下载：27/0  |  提交时间：2019/12/05
Recombinant humanized anti-PD-1 monoclonal antibody (JS001) in patients with refractory/metastatic nasopharyngeal carcinoma: Preliminary results of an open-label phase II clinical study 会议论文
作者:  Xu, R.;  Wang, F. H.;  Feng, F. J.;  Li, Q.;  Xu, N.
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05
Clinical Characterization of ERBB2 Exon 20 Insertions and Heterogeneity of Outcomes to Afatinib in Chinese Lung Cancers 会议论文
作者:  Hu, Y.;  Liu, Z.;  Wu, L.;  Cao, J.;  Yang, Z.
收藏  |  浏览/下载：33/0  |  提交时间：2019/12/05
Preliminary safety, pharmacokinetics (PK) and efficacy results from a phase I study of CS1001, an anti-programmed death ligand-1 (PD-L1) monoclonal antibody (mAb) in patients (pts) with advanced tumors 会议论文
作者:  Shen, L.;  Cao, J.;  Gong, J.;  Ji, D.;  Qin, Z.
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05
Clinical Characterization Of ERBB2 Exon 20 Insertions and Heterogeneity of Outcomes to Afatinib in Chinese Lung Cancers 会议论文
作者:  Liu, Z.;  Hu, Y.;  Wu, L.;  Cao, J.;  Yang, Z.
收藏  |  浏览/下载：6/0  |  提交时间：2019/12/05
Pamiparib, a novel PARP 1/2 inhibitor, monotherapy for gBRCAm patients with recurrent ovarian, fallopian, and primary peritoneal cancer: An open-label, multicenter, phase II trial in China 会议论文
作者:  Wu, X.;  Wang, J.;  Zhou, Q.;  Gu, T.;  Zhang, K.
收藏  |  浏览/下载：6/0  |  提交时间：2019/12/05
Positive effects of hydrogen-water bathing in patients of psoriasis and parapsoriasis en plaques 会议论文
作者:  Zhu, Q.;  Wu, Y.;  Li, Y.;  Chen, Z.;  Wang, L.
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05
Effect of Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiotherapy on Nutritional Status in Locoregionally Advanced Nasopharyngeal Carcinoma Patients: A Prospective Observational Study 会议论文
作者:  Miao, J.;  Hu, C.;  Lin, S.;  Chen, X.;  Chen, Y.
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace